MedPath

Different Antihypertensive Drugs on Aortic Diseases

Completed
Conditions
Aortic Aneurysm
Aortic Dissection
Interventions
Drug: CCB use
Drug: non-CCB use
Registration Number
NCT06626607
Lead Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Brief Summary

The goal of this observational study is to learn about the effect of different hypotensive drugs on the prognosis of postoperative aortic patients. The main question it aims to answer is:

Does different hypotensive drugs influence the prognosis of postoperative aortic patients? As participants already taking hypotensive drugs as part of their regular medical care, the investigators collect the participants' pre-operation medical record and post-operative follow-up record to evaluate the aorta condition.

Detailed Description

This study is a cohort study that aims to explore the effects of different antihypertensive regimens on aortic remodelling in patients after aortic surgery by collecting the hospitalization and outpatient follow-up data. The study plans to gather perioperative and postoperative follow-up data from over 600 patients who underwent aortic surgery at the Eighth Affiliated Hospital and Beijing Anzhen Cardiothoracic Surgery Center. Patients were assigned based on the postoperative antihypertensive medication regimens. Datas was collected to compare the cardiovascular-related prognoses.

This study primarily includes patients who take oral antihypertensive medications after aortic surgery. The main observations will focus on postoperative complications related to the aorta (such as death, reoperation, dilation, etc.) and aortic diameters after the administration of different antihypertensive medications. Multivariate regression analysis will be employed to investigate the impact of different antihypertensive regimens on patients after aortic surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
704
Inclusion Criteria
  • aortic diseases' patients underwent aortic surgery who require antihypertensive medication.
Exclusion Criteria
  • Patients with active vasculitis;
  • Patients allergic to contrast agent
  • Patients with aorta variation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CCB groupCCB usePatients' postoperative antihypertensive includes CCB (Calcium Calcium Entry Blockers)
non-CCB groupnon-CCB usePatients' postoperative antihypertensive does not include CCB
Primary Outcome Measures
NameTimeMethod
Aortic diameterThrough the study completion, on an average of 3 years

The maximum diameter of the aorta measured by computed tomography angiography

Secondary Outcome Measures
NameTimeMethod
Number of Participants with adverse aortic eventThrough the study completion, on an average of 3 years

Postoperative adverse aortic event during follow-up, including aortic related death or reoperation

© Copyright 2025. All Rights Reserved by MedPath